Denibulin Hydrochloride

N/A

Report date: 2022/05/17 17:51:45
NME

Base Information

Drug NameDenibulin Hydrochloride
Drug Alias Name德尼布林盐酸盐盐酸德尼布林德尼布林ANG-615MN-029
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitorsVascular disrupting agents (VDA)
TargetsTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAngiogene Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A